Program

Program at a glance

*tentative (Last Updated: 2025-09-08)

Program at a glance

Special LectureNov.14, (Fri)11:30-12:10 (Noh Theatre)

Unmet Needs for Hemophilia Treatment and Management
Moderator
Midori Shima (Thrombosis and Hemostasis Research Center, Nara Medical University)
Speaker
Pantep Angchaisuksiri (Ramathibodi Hospital, Mahidol University)

Sponsored Symposium 1 Nov.13(Thu)16:50-18:30 (Noh Theatre)

Sponsored by CHUGAI PHARMACEUTICAL

Advancing Hemophilia A Care: Insights from Asia on Hemlibra's Efficacy and Experience
Moderator
Ei Kinai（Clinical Laboratory Medicine, Tokyo Medical University）
Renchi Yang （National Hemophilia Registry Center, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College）
Speaker
Current status and future perspective on hemophilia care in China Mainland
Renchi Yang  (National Hemophilia Registry Center, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College)
From clinical trials to real world practice of hemophilia A patients
Yeu-Chin Chen (Hemophilia care and research center  in Tri-Service General Hospital)
Real-World Evidence of Emicizumab in Korea
Seung-min Hahn  (Department of Pediatrics, Severance Hospital Yonsei University College of Medicine)
Efficacy and safety of Hemlibra　～Update the evidence～
Ei Kinai  (Clinical Laboratory Medicine, Tokyo Medical University)

Sponsored Symposium 2Nov.14(Fri)9:50-11:30 (Noh Theatre)

Sponsored by Novo Nordisk Pharma

Alhemo® in haemophilia, what unmet needs does an anti-TFPI rebalancing agent address?
Moderator
Nobuaki Suzuki (Department of Transfusion Medicine, Nagoya University Hospital)
Midori Shima (Thrombosis and Hemostasis Research Center, Nara Medical University)
Speaker
Mechanism of anti-TFPI rebalancing therapy with Alhemo® and its clinical outcome
Seung-min Hahn (Pediatric Oncology Center, Yonsei Cancer Hospital)
Safety and efficacy of concizumab prophylaxis in people with hemophilia A or hemophilia B without inhibitors in phase 3a trial explorer8
Pratima Chowdary (Haemophilia and Haemostasis, University College London, Katharine Dormandy Haemophilia & Thrombosis Centre Royal Free Hospital)

Sponsored Symposium 3　Nov.14(Fri)13:20-15:00 (Noh Theatre)

Sponsored by Takeda Pharmaceutical

Forefront of Diagnosis and Treatment for von Willebrand Disease
Moderator
Kenichi Ogiwara (Department of Padiatrics, Nara Medical University)
Speaker
Kun Soo Lee（Department of Pediatrics, Kyungpook National University School of Medicine）
Diagnosis and Treatment of von Willebrand disease in Taiwan
Yeu-Chin Chen（Hemophilia Care & Research Center, Tri-Service General Hospital）
Update and challenges of VWD Treatment in Japan
Kenichi Ogiwara（Department of Pediatrics, Nara Medical University）

Sponsored Symposium 4　Nov.14(Fri)15:10-16:50 (Noh Theatre)

Sponsored by CSL Behring

CSL Medical Affairs Symposium
Advancing to a new treatment paradigm: Gene Replacement Therapy
Moderator
Eun Jin Choi (Daegu Catholic University Medical Center)
Speaker
Gene Therapy in Japan：regulatory aspects and current clinical set-up
Yoshikazu Yonemitsu (R&D Laboratory for Innovative Biotherapeutics Kyushu University Graduate School of Pharmaceutical Sciences)
Implementing Shared Decision-Making in Hemophilia Care
Azusa Nagao (Department of Hematology-Oncology, Kansai Medical University Hospital)
Gene Therapy for Hemophilia: Translating Clinical Trial Experiences to Real-World in Taiwan
Sheng-Chieh, Chou (Department of Internal Medicine, National Taiwan University Hospital (NTUH))

Sponsored Symposium 5　Nov.15(Sat)9:50-11:30 (Noh Theatre)

Sponsored by Sanofi

Evolving ecosystems for Hemophilia Care in East Asia: Country Models and Collaborative Innovation
Moderator
Masahiro Takeyama (Division of Hemophilia, Osaka National Hospital)
Ming-Ching Shen (Department of Internal Medicine, Changhua Christian Hospital)
Speaker
Building a Regional Hemophilia Network in Japan: A Block Hemophilia Center’s Experience in Multidisciplinary and Inter-Hospital Collaboration and Registry Launch
Masahiro Takeyama (Division of Hemophilia, Osaka National Hospital)
Advancing Comprehensive Hemophilia Care in Korea: The Role of the Korea Hemophilia Foundation
Hong hoe Koo (Korea Hemophilia Foundation)
Advancing Hemophilia A Care in Taiwan: A Model of Comprehensive Treatment and Data-Driven Collaboration
Shyh-Shin Chiou (1.College of Medicine, Kaohsiung Medical University
2. Department of Pediatrics, Kaohsiung Medical University Hospital)
Hemophilia Center Evaluation and Accreditation Project in China: Advancing Tiered, Equitable Care for Hemophilia Patients
Feng Xue　(Chinese Academy of Medical Sciences & Peking Union Medical College Hospital of Hematology)

Welcome Seminar 1Nov.13(Thu)16:00-16:45 (Noh Theatre)

Sponsored by Novo Nordisk Pharma

Moderator
Takeshi Matsumoto (Department of Transfusion Medicine and Cell Therapy, Saitama Medical Center)
Speaker
Management Strategies for Hemophilia and Associated Comorbidities
Jiaan Der, Wang (Center for Rare Disease and Hemophilia, Taichung Veterans General Hospital)

Welcome Seminar 2Nov.13(Thu)16:00-16:45 (Conference Room 1)

Sponsored by CSL Behring

Moderator
Pantep Angchaisuksiri (Ramathibodi Hospital, Mahidol University)
Speaker
Current situation of peoples with hemophilia B in Japan and practical sharing of clinical experience in IDELVION
Keiji Nogami (Department of Pediatrics, Nara Medical University)

Morning Seminar 1Nov.14(Fri)08:00-08:45 (Conference Room 1)

Sponsored by KM Biologics

Moderator
Sang Kyu Park (Korea Hemophilia Foundation Busan Clinic)
Speaker
The usefulness of pd-FVIIa/FX in hemostatic treatment of hemophilia inhibitors
Yuto Nakajima (Department of Pediatrics, Nara Medical University)
Understanding the bypass pathways of coagulation : For management of optimal hemostasis in patients with inhibitors
Mitsuhiro Uchiba (Department of Transfusion Medicine and Cell Therapy, Kumamoto University Hospital)

Morning Seminar 2Nov.15(Sat)08:00-08:45 (Conference Room 1)

Sponsored by SEKISUI CHEMICAL

Moderator
Ki-Young Yoo (Korea Hemophilia Foundation, Seoul clinic)
Speaker
Clinical application and advances of clot waveform analysis in the hemorrhagic and thrombotic disorders
Keiji Nogami (Department of Pediatrics, Nara Medical University)

Luncheon Seminar 1Nov.14(Fri)12:20-13:05 (Conference Room 1)

Sponsored by Pfizer Japan

Anti-TFPI Agent
Moderator
Teruhisa Fujii
Speaker
Marstacimab: Rational for fixed dose and the latest safety and efficacy data from the Phase 3 BASIS study
Johnny Mahlangu (Department of Molecular Medicine and Haematology, Univerity of the Witwatersrand)

Luncheon Seminar 2　Nov.15(Sat)11:40-12:25 (Conference Room 1)

Sponsored by Japan Blood Products Organization

Hemophilia in Japan and around the world
Moderator
Tai Ju Hwang (Chonnam National University)
Speaker
Global trends in the hemophilia healthcare environment and WFH (World Federation of Hemophilia)
Yasuharu Nishida (Division of Hemophilia, Osaka National Hospital)
Healthcare of Haemophilia in Japan, Historical Issues and Current Challenges, and Future Strategies
Katsuyuki Fukutake (Ogikubo Hospital)

Evening Seminar 1Nov.14(Fri)18:00-18:45 (Noh Theatre)

Sponsored by CHUGAI PHARMACEUTICAL

From Current Excellence to Future Breakthroughs: The Evolution of Hemophilia A Treatment
Moderator
Runhui Wu (Beijing Children’s Hospital, Capital Medical University)
Speaker
Recent Advances and Future Directions in Hemlibra Therapy for
Hemophilia   A
Keiji Nogami (Department of Pediatrics, Nara Medical University)

Evening Seminar 2Nov.14(Fri)18:00-18:45 (Conference Room 1)

Sponsored by Sanofi

Advancing Hemophilia A Care: ALTUVIIIO's Impact Across Age Groups and Regions
Moderator
Chia-Yau Chang (Taipei Medical University Hospital)
Speaker
Clinical Insights into ALTUVIIIO in Hemophilia A: Trial Evidence and Real world Clinical Experience of Product Switching in Multi-centers in Taiwan
Chia-Yau Chang　(Taipei Medical University Hospital)
ALTUVIIIO in Children with Hemophilia A: Clinical Insights from the XTEND-Kids Study and Real-World Experience from a Single Center
Rie Shirayama (University of Occupational and Environmental Health)

Farewell SeminarNov.15(Sat)12:40-13:25 (Noh Theatre)

Sponsored by Bayer Yakuhin

Moderator
Tadashi Matsushita (Department of Transfusion Medicine, Nagoya University Hospital)
Speaker
Simplicity Through Mastery, Proven by Time: Recombinant FVIII
– The Cornerstone of Hemophilia Treatment
Renchi Yang (Institute of Haematology and Blood Diseases Hospital)

General Session 1Nov.13(Thu)15:10-16:00 (Noh Theatre)

Current Situation of Hemophilia
Moderator
Atsuki Yamashita (Department of Pediatrics, St. Marianna University School of Medicine)
Zhenping Chen (Beijing Children’s Hospital, Capital Medical University)
Speaker
Current Situation of Hemophilia Care in Taiwan
Chia-Yau Chang (Department of Pediatrics, Taipei Medical University Hospital / Department of Pediatrics, Taipei Medical University) Current Situation of Hemophilia in Korea
Hwi-Joong Yoon (College of Medicine, Kyung Hee University)
Nationwide Survey on Hemophilia Care in Japan 2024: Prophylaxis, Treatment Patterns, and Inhibitor Status
Takeshi Matsumoto (Department of Transfusion Medicine and Cell Therapy, Saitama Medical Center, Saitama Medical University)
TBA
Zhenping Chen (Beijing Children’s Hospital, Capital Medical University)

General Session 2Nov.13(Thu)15:10-16:00 (Conference Room 1)

Basic Science / Novel Therapy
Moderator
Asuka Sakata (Department of Blood Transfusion Medicine, Nara Medical University)
Takashi Ito (Department of Hematology and Immunology, Faculty of Life Sciences, Kumamoto
Speaker
TBA
Seung-min Hahn (Pediatric Oncology Center, Yonsei Cancer Hospital)
Evaluation of factor VIII inhibitor risk under emicizumab prophylaxis using hemophilia A murine models with long-term expression of human factors IX and X
Sheng-Chieh Chou (Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan)
Novel Gene Therapy Appreoach for Hemophilia
Tsukasa Ohmori（Jichi Medical University）
Multicenter Clinical Cohort Study of Idiopathic Acquired Hemophilia A: Treatment Outcomes, Prognostic Factors, and Immune Profiling
Xuan Zhou（Nanfang Hospital, Southern Medical University）

General Session 3 Nov.14(Fri)09:00-09:50 (Noh Theatre)

Carriers of Hemophilia
Moderator
Masato Bingo (Department of Laboratory Medicine, Tokyo Medical University)
Yongqiang Zhao (TBA)
Speaker
Clinical Application of Factor VIII:C to VWF:Ag Ratio for the Screening of Hemophilia A Carriers in Korea
Ji Kyoung Park（Department of Pediatrics, Busan Paik Hospital, Inje University College of Medicine）
Carrier of Haemophilia
Jing Dai（Shanghai Jiaotong University School of Medicine Affiliated Ruijin Hospital）
Genetic Diagnostics in Hemophilia Carriers in Japan: From Variant Diversity to Variable Expressivity
Keiko Shinozawa（Department of Laboratory Medicine, Tokyo Medical University） Carriers of Hemophilia
Ming-Ching Shen（Hemophilia Treatment and Thrombosis Center, Department of Internal Medicine, Changhua Christian Hospital / Department of Internal Medicine, National Taiwan University Hospital / Department of Laboratory Medicine, National Taiwan University Hospital）

General Session 4Nov.14(Fri)09:00-09:50 (Conference Room 1)

Aging / Comorbidities
Moderator
Naruto Shimonishi（The Course of Thrombosis and Hemostasis Molecular Pathology, Nara Medical University）
Yushi Chikazawa(Department of Laboratory Medicine, Tokyo Medical University Hospital)
Speaker
Managing Thrombosis in Aging Hemophilia Patients: Insights from the ADVANCE Japan
Azusa Nagao（Kansai Medical University Hospital）
TBA
Hee Jo Baek（Chonnam National University Hwasun）
Comprehensive Management of Comorbidities in Middle-Aged and Elderly Patients with Hemophilia: Current Insights and Perspectives from a Single Center in china
Huacong Cai（Department of Hematology, Peking Union Medical College Hospital）
Beyond Bleeding: Managing Age-Related Comorbidities in Persons with Hemophilia
Jiaan-Der Wang （Center for Rare Disease and Hemophilia, Taichung Veterans General Hospital）

General Session 5Nov.15(Sat)09:00-09:50 (Noh Theatre)

Registry / Care Network
Moderator
Reiji Fukano（Department of Pediatrics, University of Occupational and Environmental Health)
Tai Ju Hwang（Profesor Emeritus, Chonnam National University)
Speaker
Hemophilia Center Evaluation and Accreditation Project in China: Advancing Tiered, Equitable Care for Hemophilia Patients
Feng Xue（Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College）
Current status of Korean Bleeding Disorders Registry (KBDR) operated by Korean Society of Hemophilia (KSH) in Korea
Jung Woo Han（Department of Pediatrics, Yonsei University College of Medicine, Yonsei University Health System）
Japan’s new challenge ~Japan bleeding disorder registry~
Nobuaki Suzuki（Department of transfusion medicine, Nagoya university hospital）
TBA
Shyh-Shin Chiou（Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University / Division of Hematology&Oncology, Department of Pediatrics, Kaohsiung Medical University Hospital）

General Session 6Nov.15(Sat)09:00-09:50 (Conference Room 1)

Joint Health (Assessment / Surgery / Rehabilitation)
Moderator
Hideyuki Takedani（Department of Rehabilitation, NHO Tsuruga Medical Center）
Tazuko Tokugawa（Department of Respiratory Medicine and Hematology, Hyogo Medical University）
Speaker
Computer-Assisted Total Knee Arthroplasty in Patients with Haemophilia
Kang-il Kim（Department of Orthopaedics, Kyung Hee University Hospital at Gangdong, Medical college of Kyung Hee University）
The evaluation of sarcopenia and its association with joint disorders in people with hemophilia over 40 years in Japan.
Kumiko Ono（Division of Therapeutic Development for Intractable Bone Diseases, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo）
Surgical treatment of hemophilic clubfoot
Dong Dong Wan（Tianjin first central hospital）
Management of Hemophilic Arthopathy in Taiwan
Yeu-Chin Chen（Associate Professor, Hemophilia Care & Research Center, Division of Hematology/Oncology, Tri-Service General Hospital (TSGH), National Defense Medical Center）
BACK TO TOP